Trichy Daily

Sjogren’s Syndrome Market, Size, Share, Trends, Epidemiology Forecast till 2030

 Breaking News
  • No posts were found

Sjogren’s Syndrome Market, Size, Share, Trends, Epidemiology Forecast till 2030

July 15
19:01 2020
Sjogren's Syndrome Market, Size, Share, Trends, Epidemiology Forecast till 2030

DelveInsight
DelveInsight’s “Sjogren’s Syndrome Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Sjogren’s Syndrome, historical and forecasted epidemiology as well as the Sjogren’s Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Sjogren’s syndrome (SS) is a chronic autoimmune rheumatic disease with specific predisposition for causing inflammation of the exocrine glands, predominantly the salivary and lacrimal glands, including the nose, upper respiratory tract, oropharynx and the vagina in women.

Some of the key facts of the report:-

* As per DelveInsight estimates, total cases of Sjogren’s syndrome (SS) in the 7MM was found to be 3,270,396 in 2017.

* Among all the countries, the United States accounts for higher population of Sjogren’s syndrome (SS) with 1,676,238 cases in 2017. 

* Among the EU5 countries, UK had the highest diagnosed prevalent population of Sjögren’s syndrome followed by Germany. On the other hand, Spain had the lowest prevalent population.

* As per DelveInsight estimates, among the 7MM, Japan had the lowest diagnosed prevalent population of Sjögren’s syndrome in 2017.

* Females are more prone to SS than males in all countries. In 2017, there were 167,624 prevalent cases of Sjögren’s syndrome in males and 1,508,614 prevalent cases in females.  

 

Scope of the Sjogren’s syndrome Market Report

  • The report covers the descriptive overview of Sjogren’s Syndrome, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Sjogren’s Syndrome epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Sjogren’s Syndrome are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Sjogren’s Syndrome market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Sjogren’s Syndrome market

Request for sample pages

 

Currently, the therapeutic market size of Sjögren’s syndrome is mainly accounted by symptomatic treatment using the local therapies like pilocarpine, cevimeline, topical fluoride, topical cyclosporine, autologous serum eye drops, and, systemic therapies like corticosteroids, hydroxychloroquine, immunosuppressants (Methotrexate (MTX), Cyclosporine A, Azathioprine, Leflunomide, and Mycophenolic acid). Moreover, biological therapy with Rituximab is in extensive use for the US market.

Local therapy generally includes the treatment of sicca symptoms. For the treatment of dry eyes, tear substitution therapy consisting of high-viscosity eye drops and gels, in combination with oral mucolytic agents to dissolve mucus, is the mainstay treatment. Patients with Sjögren’s syndrome associated severe or refractory keratoconjunctivitis sicca might require a short-term course of topical anti-inflammatory agents such as topical cyclosporine. In most refractory cases, autologous serum eye drops, and temporary occlusion of the puncta are used.

Table of contents

1. Key Insights

2. Executive Summary of Sjogren’s Syndrome

3. Competitive Intelligence Analysis for Sjogren’s Syndrome

4. Sjogren’s Syndrome: Market Overview at a Glance

5. Sjogren’s Syndrome: Disease Background and Overview

6. Patient Journey

7. Sjogren’s Syndrome Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Sjogren’s Syndrome Treatment and Management

8.2. Sjogren’s Syndrome Treatment Algorithm 

9. Unmet Needs

10. Key Endpoints of Sjogren’s Syndrome Treatment

11. Marketed Products

12. Emerging Therapies

13. Sjogren’s Syndrome: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

15.1. United States: Market Size

15.1.1. Sjogren’s Syndrome Total Market Size in the United States

15.1.2. Sjogren’s Syndrome Market Size by Therapies in the United States

15.2. EU-5 countries: Market Size and Outlook

15.3. Germany Market Size

15.3.1. Sjogren’s Syndrome Total Market Size in Germany

15.3.2. Sjogren’s Syndrome Market Size by Therapies in Germany

15.4. France Market Size

15.4.1. Sjogren’s Syndrome Total Market Size in France

15.4.2. Sjogren’s Syndrome Market Size by Therapies in France

15.5. Italy Market Size

15.5.1. Sjogren’s Syndrome Total Market Size in Italy

15.5.2. Sjogren’s Syndrome Market Size by Therapies in Italy

15.6. Spain Market Size

15.6.1. Sjogren’s Syndrome Total Market Size in Spain

15.6.2. Sjogren’s Syndrome Market Size by Therapies in Spain

15.7. United Kingdom Market Size

15.7.1. Sjogren’s Syndrome Total Market Size in the United Kingdom

15.7.2. Sjogren’s Syndrome Market Size by Therapies in the United Kingdom

15.8. Japan Market Outlook

15.8.1. Japan Market Size

15.8.2. Sjogren’s Syndrome Total Market Size in Japan

15.8.3. Sjogren’s Syndrome Market Size by Therapies in Japan

16. Access and Reimbursement Overview of Sjogren’s Syndrome

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

Media Contact
Company Name: DelveInsight
Contact Person: Priya Maurya
Email: Send Email
Phone: +919650213330
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

Related Articles